Oncorus, Inc.
ONCR
ONCR was delisted on the 20th of June, 2023.
0 hedge funds and large institutions have $0 invested in Oncorus, Inc. in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $3 → $0 (-$3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YAL
Your Advocates Ltd
Houston,
Texas
|
-$3 |
ONCR Hedge Fund Activity: Q4 2023 in Review
0 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Oncorus, Inc. (ONCR) for Q4 2023, worth a combined $0 — down 100% from $3 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ONCR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Your Advocates Ltd, exiting entirely with an estimated $3 sold.
- 0 institutional investors held Oncorus, Inc. (ONCR) as of Q4 2023, down from 1 in Q3 2023.
- Funds reported $0 of Oncorus, Inc. stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new Oncorus, Inc. positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest Oncorus, Inc. seller in Q4 2023 was Your Advocates Ltd, an estimated $3 sold.
Based on aggregated 13F filings for Q4 2023.